Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
eltoprazine | 5-ht 1a receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Dyskinetic syndrome[MeSHID:D020820] Parkinson Disease[MeSHID:D010300] Attention deficit hyperactivity disorder[MeSHID:D001289] |
0.2 | phase 3 | unknown |
eltoprazine | 5-ht 1b receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Dyskinetic syndrome[MeSHID:D020820] Parkinson Disease[MeSHID:D010300] Attention deficit hyperactivity disorder[MeSHID:D001289] |
0.33 | phase 3 | unknown |
eltoprazine | 5-ht 2c receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Dyskinetic syndrome[MeSHID:D020820] Parkinson Disease[MeSHID:D010300] Attention deficit hyperactivity disorder[MeSHID:D001289] |
0.22 | phase 3 | unknown |
click here to return to the previous page |